Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111393329A details a high-yield synthesis of BDH, a key ritonavir intermediate, utilizing stereoselective reduction for cost-effective manufacturing.
Novel synthesis route avoids azide risks and reduces steps for high-purity pharmaceutical intermediates manufacturing with significant cost advantages.
Patent CN115724792A reveals a streamlined ammonolysis route for Edoxaban intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN110483420A details rhodium-catalyzed tetrahydroquinoxaline synthesis using water. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107805225B reveals a green synthesis route for 5-mercapto tetrazole acetic acid, eliminating toxic methyl iodide and enabling cost-effective industrial scale-up for ceforanide production.
Patent CN1046709C details a scalable palladium-catalyzed vinyl substitution for pyridine derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111763150B reveals a novel L-glutamic acid resolution method for high-purity sertraline, offering significant cost reduction and supply chain reliability for global buyers.
Advanced synthesis of 5-mercapto tetrazole acetic acid via patent CN107805225B. Offers superior yield, safety, and cost reduction for ceforanide intermediate supply chains.
Patent CN1660842A details an improved route for cardiovascular API intermediates. Discover cost-effective manufacturing and scalable pyridone synthesis strategies.
Novel oxidation method for N-(2-aminoethyl) glycine derivatives ensures high purity and scalable production for pharmaceutical intermediates supply chains.
Patent CN108505063A enables green electrochemical synthesis. Offers high purity pharmaceutical intermediates with reduced energy consumption and scalable production capabilities.
Novel Fmoc solid-phase route for Telaprevir reduces cost and complexity. High purity API intermediate manufacturing solution for global supply chains.
Novel solid-phase synthesis of Goserelin avoids palladium reduction. Enhances purity and supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN113024615A discloses efficient chiral ligands enabling cheap metal catalysis for API synthesis, offering significant cost reduction and supply chain stability.
Novel cyanide-free synthesis route for epinastine intermediate ensuring high purity and supply chain safety for global pharmaceutical manufacturing partners seeking reliable production.
High-yield synthesis method for pyrazolopyridine intermediates offering cost reduction and supply reliability for pharmaceutical manufacturing partners globally.
Patent CN102249974A details a high-purity crystallization method for Levo-Oxiracetam, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115991667A details a novel Pd-catalyzed method for synthesizing chiral 3-substituted indolines with high enantioselectivity, offering cost-effective solutions for API manufacturing.
Patent CN107805218B reveals a novel 2-step route for 4-Boc-aminopiperidine. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable technology.
Patent CN119735606B details visible-light synthesis of gem-bis boron cyclopropanes. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.